HLA-DR Antikörper (FITC)
Kurzübersicht für HLA-DR Antikörper (FITC) (ABIN120139)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Affinity chromatography on Protein G
-
Immunogen
- EHR-B Ramos cells. Spleen cells from immunised AO rats were fused with cells of the rat Y3 Ag1.2.3 myeloma cell line.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
Flow Cytometry: Neat - 1/10, Use 10 μL of the suggested working dilution to label 10^6 cells in 100 μL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.1 mg/mL
-
Buffer
- Containing 0.09 % Sodium Azide and 1 % Bovine Serum Albumin
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing. Should this product contain a precipitate we recommend microcentrifugation before use.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- HLA-DR
-
Andere Bezeichnung
- HLA Class II DR
-
Hintergrund
- HLA DR is expressed by B lymphocytes, activated T cells and by monocytes.Synonyms: HLA class II histocompatibility antigen DR, HLA-DR, MHC class II antigen DR
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-